ArticleNature2019
Neoantigen vaccine generates intratumoral T cell responses in phase Ib glioblastoma trial.
Derin B Keskin et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
914 papers cite itlatest 60 shown
this paperpooled ittrialcites it